Home >> Life Sciences >> Medical Devices

Global Female Contraception Drug Market Report 2018 by Manufacturer, Region, Type and Application, Forecast to 2023

Published: May-2018 | Format: PDF | XYZResearch | Number of pages: 107 | Code: MRS - 250118

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Female Contraception Drug for these regions, from 2012 to 2023 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

Global Female Contraception Drug market competition by top manufacturers/players, with Female Contraception Drug sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Addex Therapeutics Ltd
    Agile Therapeutics Inc
    Bayer AG
    Evofem Inc
    Hervana Ltd
    Mithra Pharmaceuticals SA
    Orbis Biosciences Inc
    Teva Pharmaceutical Industries Ltd
    Viramal Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    AG-890
    Amphora
    BAY-1007626
    Drospirenone
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Female Contraception Drug for each application, including
    Clinic
    Hospital
    Homecare

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents

Global Female Contraception Drug Sales Market Report 2018 by Manufacturer, Region, Type and Application
1 Female Contraception Drug Market Overview
    1.1 Product Overview and Scope of Female Contraception Drug
    1.2 Classification of Female Contraception Drug by Product Category
        1.2.1 Global Female Contraception Drug Market Size (Sales) Comparison by Type (2012-2023)
        1.2.2 Global Female Contraception Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 AG-890
        1.2.4 Amphora
        1.2.5 BAY-1007626
        1.2.6 Drospirenone
        1.2.7 Others
    1.3 Global Female Contraception Drug Market by Application/End Users
        1.3.1 Global Female Contraception Drug Sales (Volume) and Market Share Comparison by Application (2012-2023)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Homecare
    1.4 Global Female Contraception Drug Market by Region
        1.4.1 Global Female Contraception Drug Market Size (Value) Comparison by Region (2012-2023)
        1.4.2 North America Female Contraception Drug Status and Prospect (2012-2023)
        1.4.3 Europe Female Contraception Drug Status and Prospect (2012-2023)
        1.4.4 China Female Contraception Drug Status and Prospect (2012-2023)
        1.4.5 Japan Female Contraception Drug Status and Prospect (2012-2023)
        1.4.6 Southeast Asia Female Contraception Drug Status and Prospect (2012-2023)
        1.4.7 India Female Contraception Drug Status and Prospect (2012-2023)
    1.5 Global Market Size (Value and Volume) of Female Contraception Drug (2012-2023)
        1.5.1 Global Female Contraception Drug Sales and Growth Rate (2012-2023)
        1.5.2 Global Female Contraception Drug Revenue and Growth Rate (2012-2023)

2 Industrial Chain Analysis
     2.1 Industry Chain Structure of Female Contraception Drug 
     2.2 Raw Material Analysis of Female Contraception Drug 
        2.1.1 Raw Material A Market Analysis
        2.1.2 Raw Material B Market Analysis
        2.1.3 Raw Material C Market Analysis
    2.3 Labor Cost Analysis of Female Contraception Drug 
    2.4 Other Costs Analysis of Female Contraception Drug
    2.5 Manufacturing Cost Structure Analysis of Female Contraception Drug
    2.6 Manufacturing Process Analysis of Female Contraception Drug
    2.7 Raw Materials Sources of Female Contraception Drug Major Manufacturers in 2017
    2.8 Downstream Buyers

3 Global Female Contraception Drug Players/Suppliers Profiles and Sales Data
    3.1 Addex Therapeutics Ltd
        3.1.1 Company Basic Information, Manufacturing Base and Competitors
        3.1.2 Female Contraception Drug Product Category, Application and Specification
            3.1.2.1 Product A
            3.1.2.2 Product B
        3.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.1.4 Addex Therapeutics Ltd Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.1.5 Addex Therapeutics Ltd Female Contraception Drug Volume in Different Applications and Its Application Share
    3.2 Agile Therapeutics Inc
        3.2.1 Company Basic Information, Manufacturing Base and Competitors
        3.2.2 Female Contraception Drug Product Category, Application and Specification
            3.2.2.1 Product A
            3.2.2.2 Product B
        3.2.3 Agile Therapeutics Inc Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.2.4 Agile Therapeutics Inc Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.2.5 Agile Therapeutics Inc Female Contraception Drug Volume in Different Applications and Its Application Share
    3.3 Bayer AG
        3.3.1 Company Basic Information, Manufacturing Base and Competitors
        3.3.2 Female Contraception Drug Product Category, Application and Specification
            3.3.2.1 Product A
            3.3.2.2 Product B
        3.3.3 Bayer AG Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.3.4 Bayer AG Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.3.5 Bayer AG Female Contraception Drug Volume in Different Applications and Its Application Share
    3.4 Evofem Inc
        3.4.1 Company Basic Information, Manufacturing Base and Competitors
        3.4.2 Female Contraception Drug Product Category, Application and Specification
            3.4.2.1 Product A
            3.4.2.2 Product B
        3.4.3 Evofem Inc Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.4.4 Evofem Inc Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.4.5 Evofem Inc Female Contraception Drug Volume in Different Applications and Its Application Share
    3.5 Hervana Ltd
        3.5.1 Company Basic Information, Manufacturing Base and Competitors
        3.5.2 Female Contraception Drug Product Category, Application and Specification
            3.5.2.1 Product A
            3.5.2.2 Product B
        3.5.3 Hervana Ltd Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.5.4 Hervana Ltd Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.5.5 Hervana Ltd Female Contraception Drug Volume in Different Applications and Its Application Share
    3.6 Mithra Pharmaceuticals SA
        3.6.1 Company Basic Information, Manufacturing Base and Competitors
        3.6.2 Female Contraception Drug Product Category, Application and Specification
            3.6.2.1 Product A
            3.6.2.2 Product B
        3.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.6.4 Mithra Pharmaceuticals SA Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.6.5 Mithra Pharmaceuticals SA Female Contraception Drug Volume in Different Applications and Its Application Share
    3.7 Orbis Biosciences Inc
        3.7.1 Company Basic Information, Manufacturing Base and Competitors
        3.7.2 Female Contraception Drug Product Category, Application and Specification
            3.7.2.1 Product A
            3.7.2.2 Product B
        3.7.3 Orbis Biosciences Inc Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.7.4 Orbis Biosciences Inc Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.7.5 Orbis Biosciences Inc Female Contraception Drug Volume in Different Applications and Its Application Share
    3.8 Teva Pharmaceutical Industries Ltd
        3.8.1 Company Basic Information, Manufacturing Base and Competitors
        3.8.2 Female Contraception Drug Product Category, Application and Specification
            3.8.2.1 Product A
            3.8.2.2 Product B
        3.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.8.4 Teva Pharmaceutical Industries Ltd Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.8.5 Teva Pharmaceutical Industries Ltd Female Contraception Drug Volume in Different Applications and Its Application Share
    3.9 Viramal Ltd
        3.9.1 Company Basic Information, Manufacturing Base and Competitors
        3.9.2 Female Contraception Drug Product Category, Application and Specification
            3.9.2.1 Product A
            3.9.2.2 Product B
        3.9.3 Viramal Ltd Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.9.4 Viramal Ltd Different Types of Female Contraception Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
        3.9.5 Viramal Ltd Female Contraception Drug Volume in Different Applications and Its Application Share

4 Global  Female Contraception Drug Market Competition by Players
    4.1  Global  Female Contraception Drug Sales (K Units) and Market Share (%) of Key Players (2012-2017)
        4.1.1  Global  Female Contraception Drug Sales (K Units) and Market Share (%) of Key Players (2012-2017)
        4.1.2  Global  Female Contraception Drug Revenue (Million USD) and Share by Players (2012-2017)
    4.2  Global  Female Contraception Drug Sales and Revenue by Type
        4.1.1  Global  Female Contraception Drug Sales (K Units) and Market Share (%) by Type (2012-2017)
        4.1.2  Global  Female Contraception Drug Revenue (Million USD) and Market Share (%) by Type (2012-2017)
    4.3  Global  Female Contraception Drug Sales and Revenue by Regions
        4.3.1  Global  Female Contraception Drug  Sales (K Units) and Market Share (%) by Regions (2012-2017)
        4.3.2  Global  Female Contraception Drug Revenue and Market Share (%) by Regions (2012-2017)
    4.4  Global  Female Contraception Drug Revenue and Market Share (%) by Regions (2012-2017)

5 North America Female Contraception Drug (Volume, Value and Sales Price)
    5.1 North America Female Contraception Drug Sales and Value (2012-2017)
        5.1.1 North America Female Contraception Drug Sales and Growth Rate (2012-2017)
        5.1.2 North America Female Contraception Drug Revenue and Growth Rate (2012-2017)
        5.1.3 North America Female Contraception Drug Sales Price Trend (2012-2017)
    5.2 North America Female Contraception Drug Sales Volume and Market Share by Players
    5.3 North America Female Contraception Drug Sales Volume and Market Share by Type
    5.4 North America Female Contraception Drug Sales Volume and Market Share by Application

6 Europe Female Contraception Drug (Volume, Value and Sales Price)
    6.1 Europe Female Contraception Drug Sales and Value (2012-2017)
        6.1.1 Europe Female Contraception Drug Sales and Growth Rate (2012-2017)
        6.1.2 Europe Female Contraception Drug Revenue and Growth Rate (2012-2017)
        6.1.3 Europe Female Contraception Drug Sales Price Trend (2012-2017)
    6.2 Europe Female Contraception Drug Sales Volume and Market Share by Players
    6.3 Europe Female Contraception Drug Sales Volume and Market Share by Type
    6.4 Europe Female Contraception Drug Sales Volume and Market Share by Application

7 China Female Contraception Drug (Volume, Value and Sales Price)
    7.1 China Female Contraception Drug Sales and Value (2012-2017)
        7.1.1 China Female Contraception Drug Sales and Growth Rate (2012-2017)
        7.1.2 China Female Contraception Drug Revenue and Growth Rate (2012-2017)
        7.1.3 China Female Contraception Drug Sales Price Trend (2012-2017)
    7.2 China Female Contraception Drug Sales Volume and Market Share by Players
    7.3 China Female Contraception Drug Sales Volume and Market Share by Type
    7.4 China Female Contraception Drug Sales Volume and Market Share by Application

8 Japan Female Contraception Drug (Volume, Value and Sales Price)
    8.1 Japan Female Contraception Drug Sales and Value (2012-2017)
        8.1.1 Japan Female Contraception Drug Sales and Growth Rate (2012-2017)
        8.1.2 Japan Female Contraception Drug Revenue and Growth Rate (2012-2017)
        8.1.3 Japan Female Contraception Drug Sales Price Trend (2012-2017)
    8.2 Japan Female Contraception Drug Sales Volume and Market Share by Players
    8.3 Japan Female Contraception Drug Sales Volume and Market Share by Type
    8.4 Japan Female Contraception Drug Sales Volume and Market Share by Application

9 Southeast Asia Female Contraception Drug (Volume, Value and Sales Price)
    9.1 Southeast Asia Female Contraception Drug Sales and Value (2012-2017)
        9.1.1 Southeast Asia Female Contraception Drug Sales and Growth Rate (2012-2017)
        9.1.2 Southeast Asia Female Contraception Drug Revenue and Growth Rate (2012-2017)
        9.1.3 Southeast Asia Female Contraception Drug Sales Price Trend (2012-2017)
    9.2 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Players
    9.3 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Type
    9.4 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Application

10 India Female Contraception Drug (Volume, Value and Sales Price)
    10.1 India Female Contraception Drug Sales and Value (2012-2017)
        10.1.1 India Female Contraception Drug Sales and Growth Rate (2012-2017)
        10.1.2 India Female Contraception Drug Revenue and Growth Rate (2012-2017)
        10.1.3 India Female Contraception Drug Sales Price Trend (2012-2017)
    10.2 India Female Contraception Drug Sales Volume and Market Share by Players
    10.3 India Female Contraception Drug Sales Volume and Market Share by Type
    10.4 India Female Contraception Drug Sales Volume and Market Share by Application

11 Marketing Strategy Analysis, Distributors/Traders
    11.1 Direct Marketing
         11.1.1 Direct Marketing
         11.1.2 Indirect Marketing
         11.1.3 Marketing Channel Development Trend
    11.2 Market Positioning 
        11.2.1 Pricing Strategy 
        11.2.2 Brand Strategy 
        11.2.3 Target Client 
   11.3 Distributors/Traders List 

12 Global Female Contraception Drug Market Forecast (2018-2023)
    12.1 Global Female Contraception Drug Sales Volume, Revenue and Price Forecast (2018-2023)
       12.1.1 Global Female Contraception Drug Sales Volume and Growth Rate Forecast (2018-2023)
       12.1.2 Global Female Contraception Drug Revenue and Growth Rate Forecast (2018-2023)
       12.1.3 Global Female Contraception Drug Price and Trend Forecast (2018-2023)
    12.2 Global Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023)
       12.2.1 Global Female Contraception Drug Sales Volume and Growth Rate Forecast by Regions (2018-2023)
       12.2.2 Global Female Contraception Drug Revenue and Growth Rate Forecast by Regions (2018-2023)
       12.2.3 North America Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
       12.2.4 Europe Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
       12.2.5 China Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
       12.2.6 Japan Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
       12.2.7 Southeast Asia Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
       12.2.8 India Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
    12.3 Global Female Contraception Drug Sales Volume, Revenue and Price Forecast by Type (2018-2023)
       12.3.1 Global Female Contraception Drug Sales Forecast by Type (2018-2023)
       12.3.2 Global Female Contraception Drug Revenue Forecast by Type (2018-2023)
       12.3.3 Global Female Contraception Drug Price Forecast by Type (2018-2023)
    12.4 Global Female Contraception Drug Sales Volume Forecast by Application (2018-2023)

 13 Research Findings and Conclusion

 14 Appendix
     14.1 Methodology/Research Approach
           14.1.1 Research Programs/Design
           14.1.2 Market Size Estimation
           14.1.3 Market Breakdown and Data Triangulation
       14.2 Data Source
             14.2.1 Secondary Sources
             14.2.2 Primary Sources
       14.3 Disclaimer

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)3650 View Pricing